SCHEMBL2864929

SCHEMBL2864929

CCc1c(O)cc(O)c(C(=O)c2ccc(OC)c(OC)c2)c1CC(=O)N1CCN(c2ccccc2)CC1

nearest known ligand 0.52

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.52
KMT2A Q03164 2/20 0.52
LMNA P02545 2/20 0.51
SMN1; SMN2 Q16637 2/20 0.51
GAA P10253 1/20 0.51
HTT P42858 1/20 0.51
GFER P55789 1/20 0.48
ALDH1A1 P00352 4/20 0.48
KDM4E B2RXH2 3/20 0.48
ALOX15 P16050 1/20 0.47
NAMPT P43490 1/20 0.45
MAPT P10636 2/20 0.44
TDP1 Q9NUW8 2/20 0.44
RECQL P46063 1/20 0.44
ABCB1 P08183 1/20 0.44
HPGD P15428 2/20 0.43
HSD17B10 Q99714 2/20 0.43
USP2 O75604 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2863769 0.92 ABCB1 (0.47) MEN1KMT2ALMNASMN1; SMN2GAA
SCHEMBL15225754 0.89 MAPK1 (0.50) MEN1KMT2ALMNASMN1; SMN2GAA
SCHEMBL2869162 0.86 ME2 (0.53) MEN1KMT2ALMNAGAAHTT
SCHEMBL2864940 0.82 MAPT (0.48) KMT2ALMNAGFERALDH1A1MAPT
SCHEMBL2861836 0.80 HTT (0.47) MEN1KMT2ASMN1; SMN2HTTALDH1A1
SCHEMBL2859112 0.80 TSHR (0.51) MEN1KMT2ASMN1; SMN2GAAHTT
SCHEMBL27655770 0.78 ALDH1A1 (0.42) LMNASMN1; SMN2GAAHTTALDH1A1
SCHEMBL2860161 0.77 CYP1A2 (0.50) MEN1KMT2ASMN1; SMN2GAAALDH1A1
SCHEMBL2859704 0.76 SLC6A7 (0.53) MEN1KMT2AALDH1A1KDM4EMAPT
SCHEMBL2863214 0.76 ALDH1A1 (0.41) MEN1KMT2ALMNASMN1; SMN2GFER

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1642880-B1 HSP90 FAMILY PROTEIN INHIBITORS KYOWA HAKKO KIRIN CO LTD (JP) 2013-09-04 EP claimed
EP-1642880-B1 HSP90 FAMILY PROTEIN INHIBITORS KYOWA HAKKO KIRIN CO LTD (JP) 2013-09-04 EP disclosed
US-7767693-B2 Hsp90 family protein inhibitors KYOWA HAKKO KIRIN CO., LTD. (JP) 2010-08-03 US disclosed
US-20090247522-A1 Hsp90 FAMILY PROTEIN INHIBITORS KYOWA HAKKO KOGYO CO., LTD. (JP) 2009-10-01 US disclosed
US-7538224-B2 Hsp90 family protein inhibitors KYOWA HAKKO KOGYO CO., LTD. (JP) 2009-05-26 US disclosed
US-20070032532-A1 Hsp90 family protein inhibitors KYOWA HAKKO KOGYO CO., LTD. (JP) 2007-02-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070032532-A1 Hsp90 family protein inhibitors HSP90AB1, HSP90B1, HSP90AB2P MEN1 4773/4885KMT2A 3681/4885LMNA 4283/4885
US-20090247522-A1 Hsp90 FAMILY PROTEIN INHIBITORS HSP90AB1, HSP90B1, HSP90AB2P MEN1 4773/4885KMT2A 3681/4885LMNA 4283/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.